Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Prescribed psychiatric medication among multiple sclerosis patients before and after disability pension: a register study with matched controls.
Clinical utility and psychometric properties of the Functional Assessment of Multiple Sclerosis for individuals with multiple sclerosis.
Central Pontine and Extrapontine Myelinolysis in a Patient with Traumatic Brain Injury Following Not Rapid Correction of Hyponatremia: A Case Report.
Bilateral vertebral artery dissection in the setting of ADEM.
Cognitive Impairment and Health Related Quality of Life in Relapsing Remitting Multiple Sclerosis.
Validation of White-Matter Lesion Change Detection Methods on a Novel Publicly Available MRI Image Database.
Analysis of the Recent HTA Decision Making Landscape for Multiple Sclerosis Therapies - Trends and Future Opportunities.
Minimally Invasive En Bloc Resection of Massive Obstructive Atrial Tumour.
Gut environment-induced intraepithelial autoreactive CD4(+) T cells suppress central nervous system autoimmunity via LAG-3.
The relationship between static posturography measures and specific cognitive domains in individuals with multiple sclerosis.
The Efficacy of Functional Electrical Stimulation of the Abdominal Muscles in the Treatment of Chronic Constipation in Patients with Multiple Sclerosis: A Pilot Study.
Biochemical manifestations of the nervous tissue degradation after the blood-brain barrier opening or water intoxication in rats.
Switching from natalizumab to fingolimod: an observational study.
Gut microbiota in early pediatric multiple sclerosis: a case-control study.
Analysis of MMP2-1306C/T and TIMP2G-418C polymorphisms with relapsing remitting multiple sclerosis.
Voxel Based Morphometry in Optical Coherence Tomography: Validation & Core Findings.
Histopathological comparison of Kearns-Sayre syndrome and PGC-1α-deficient mice suggests a novel concept for vacuole formation in mitochondrial encephalopathy.
Cryopreserved vitamin D3-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients.
Natalizumab-treated patients at high risk for PML persistently excrete JC polyomavirus.
Regression-Based Norms for the Brief Visuospatial Memory Test-Revised in Italian population and application in MS patients.
Persistence with Fingolimod Versus Dimethyl Fumarate in Patients with Multiple Sclerosis: Retrospective Analysis of us Open-Source Pharmacy Data.
Evaluation of chronic inflammatory demyelinating polyneuropathy: 3D nerve-sheath signal increased with inked rest-tissue rapid acquisition of relaxation enhancement imaging (3D SHINKEI).
Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking Injectable and Oral Disease Modifying Treatments in the United States.
Integrating genome-wide association studies and gene expression data highlights dysregulated multiple sclerosis risk pathways.
Perspectives and experiences of Dutch multiple sclerosis patients and multiple sclerosis-specialized neurologists on injectable disease-modifying treatment.
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »